Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1421932-53-7
143722-25-2 | [2-[2-(Triphenylmethyl)-2H-tetrazol-5-yl]phenyl]boronic acid | AA001I7K | MFCD00521799
144025-03-6 | 2,4-Difluorophenylboronic acid | AA001IQ7 | MFCD01318998
14432-21-4 | 2-Amino-n-cyclohexylacetamide hydrochloride | AA001J92 | MFCD09027322
144584-65-6 | 1-Bromo-3-chloro-2-fluorobenzene | AA001JQ1 | MFCD03412182
1447942-88-2 | Ethyl 6,6-difluorospiro[2.5]octane-1-carboxylate | AA001K3Q | MFCD30471658
1450655-76-1 | 1H-Indole-3-carboxamide, N-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-1-[1-[1-(ethylsulfonyl)-4-piperidinyl]ethyl]-2-methyl- | AA001KFU | MFCD28167777
14532-24-2 | 1-Hexanesulfonyl chloride | AA001KQK | MFCD00038683
148625-77-8 | Fmoc-l-prolinol | AA001L0N | MFCD00235942
149104-97-2 | 1-Bromo-4-(chloromethyl)-2-methylbenzene | AA001LB6 | MFCD11110175
149489-14-5 | 2,4-Difluoro-3-formylbenzonitrile | AA001LNY | MFCD09907858